We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.5M
2
INDA icon
iShares MSCI India ETF
INDA
+$9.67M
3
IBKC
IBERIABANK Corp
IBKC
+$8.93M
4
HYT icon
BlackRock Corporate High Yield Fund
HYT
+$8.03M
5
AMZN icon
Amazon
AMZN
+$7.15M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.7M
2
NFLX icon
Netflix
NFLX
+$15.8M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$15.7M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$15.1M
5
MDCO
Medicines Co
MDCO
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATNI icon
1426
ATN International
ATNI
$481M
– –
-1,200
Closed -$66K
ATR icon
1427
AptarGroup
ATR
$8.57B
– –
-235
Closed -$27K
ATRC icon
1428
AtriCure
ATRC
$2.18B
– –
-39
Closed -$1K
OPTU
1429
Optimum Communications Inc
OPTU
$324M
– –
-100
Closed -$2.61K
AUPH icon
1430
CALL
Aurinia Pharmaceuticals
AUPH
$2.04B
– –
-1,200
Closed -$24K
AUPH icon
1431
PUT
Aurinia Pharmaceuticals
AUPH
$2.04B
– –
-3,800
Closed -$77K
AUTL
1432
Autolus Therapeutics
AUTL
$620M
– –
-460
Closed -$6K
AVGO icon
1433
Broadcom
AVGO
$1.98T
– –
-19,790
Closed -$625K
AX icon
1434
Axos Financial
AX
$5.68B
– –
-682
Closed -$21K
AXS icon
1435
CALL
AXIS Capital
AXS
$7.35B
– –
-2,100
Closed -$125K
AYI icon
1436
PUT
Acuity Brands
AYI
$10.7B
– –
-300
Closed -$41K
AZN icon
1437
AstraZeneca
AZN
$246B
– –
-534
Closed -$53K
AZTA icon
1438
Azenta
AZTA
$1.54B
– –
-1,557
Closed -$65K
BABA icon
1439
CALL
Alibaba
BABA
$306B
– –
-27,700
Closed -$5.88M
BALL icon
1440
CALL
Ball Corp
BALL
$16.6B
– –
-25,000
Closed -$1.62M
BB icon
1441
BlackBerry
BB
$5.26B
– –
-2,101
Closed -$13K
BBWI icon
1442
CALL
Bath & Body Works
BBWI
$3.81B
– –
-14,226
Closed -$208K
BC icon
1443
CALL
Brunswick
BC
$5.28B
– –
-200
Closed -$12K
BCSF icon
1444
Bain Capital Specialty
BCSF
$833M
– –
-6,624
Closed -$128K
BEN icon
1445
CALL
Franklin Resources
BEN
$16.9B
– –
-30,000
Closed -$779K
BFH icon
1446
CALL
Bread Financial
BFH
$4.36B
– –
-3,508
Closed -$314K
BHF icon
1447
CALL
Brighthouse Financial
BHF
$3.38B
– –
-7,000
Closed -$275K
BHF icon
1448
Brighthouse Financial
BHF
$3.38B
– –
-6,186
Closed -$243K
BHP icon
1449
CALL
BHP
BHP
$229B
– –
-22,420
Closed -$1.09M
BIDU icon
1450
CALL
Baidu
BIDU
$35.9B
– –
-4,800
Closed -$607K
56 57
58
59 60

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.